StatLab celebrates the commencement of injection molding manufacturing at new facility.

StatLab Medical Products (StatLab), a leading global developer and manufacturer of medical diagnostic equipment and supplies, announces the commencement of injection molding manufacturing at a new, state-of the-art histology consumable manufacturing facility in Arlington, Texas. This represents a new era of innovation and transformational opportunity for StatLab with a new essential manufacturing capability for histology solutions now actively operating in the United States.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240212393712/en/

The new StatLab histology consumable manufacturing facility, where injection molding is operational, producing histology cassettes—a critical component of the histology workflow in laboratories. (Photo: Business Wire)

Injection molding at this new 35,000 square foot facility—with room for future expansion—will give laboratories the confidence of additional core histology consumables produced by StatLab in the United States. The addition of the Arlington plant expands the StatLab in-house manufacturing network to a total of 6 locations across the United States, United Kingdom, and Germany, making the supply chain shorter, more reliable, and more effective. Onsite injection molding capabilities support not only histology cassette manufacturing but also additional components and packaging materials to further reduce the carbon footprint of products, reduce costs and empower more value for customers while offering more control over the product development ecosystem and supply chain. The successful acquisition of Wales-based CellPath Ltd. in 2022, well-known for injection molding manufacturing of histology supplies, served as a catalyst for this significant capability expansion. Other planned capability expansions at the Arlington, Texas site include blow molding as well as glass slide manufacturing.

“As we expand sales of PiSmart Cassette printers here in the U.S. market, giving customers confidence in a readily-available supply of the consumable cassettes used with the printer is imperative,” said Dae Hong, StatLab CEO. “None of this would have been possible without the help of our Newtown, Wales operational and technical teams to support this key capability expansion. We are grateful for their collaboration and partnership to build on their experience spanning more than 30 years with high-quality precision injection molding.”

The launch of new histology manufacturing capabilities at StatLab offers the flexibility to meet market needs while expanding the StatLab portfolio of manufactured cassettes to include a wide variety of styles compatible not only with the PiSmart printer, but also with other on-market printers as well as for manual use.

StatLab invites the local business and laboratory community to join us in celebration at a ribbon-cutting ceremony and open house at the new StatLab histology consumable manufacturing site in Arlington, Texas, located at 807 W Harris Rd on Thursday, February 15, 2024 at 10AM. A short reception and facility tours will follow through 2PM.

About StatLab Medical Products

StatLab Medical Products has been dedicated to helping anatomic pathology laboratories provide the best possible patient care since 1976. We offer an extensive portfolio of self-manufactured consumables and labeling and tracking equipment from six manufacturing sites in the United States, United Kingdom, and Germany. Our global operational footprint powered by over 500 mission-driven colleagues delivers a dependable and resilient supply chain of high-quality products and solutions, and a customer-centric approach inspires us to deliver reliability, innovation, and quality in every interaction. Learn more at StatLab.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240212393712/en/